US Stock MarketDetailed Quotes

CARA Cara Therapeutics

Watchlist

0.684
-0.016-2.24%

Close Apr 26 16:00 ET

0.684
0.0000.00%

Post 16:20 ET

37.41MMarket Cap-312P/E (TTM)

Cara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

-49.92%20.97M

-7.88%3M

-55.00%4.87M

-69.86%6.93M

28.71%6.17M

81.81%41.87M

297.20%3.26M

-46.66%10.81M

23M

147.55%4.79M

Operating revenue

-51.59%20.27M

-29.32%2.31M

-55.00%4.87M

-69.86%6.93M

28.71%6.17M

81.81%41.87M

297.20%3.26M

-46.66%10.81M

--23M

147.55%4.79M

Cost of revenue

-15.03%6.17M

-71.46%608K

-49.00%1.56M

1.42M

24.46%2.59M

7.27M

2.13M

3.06M

2.08M

Gross profit

-57.24%14.79M

111.85%2.4M

-57.36%3.31M

-76.02%5.52M

31.97%3.58M

50.26%34.6M

37.76%1.13M

-61.73%7.76M

23M

40.00%2.71M

Operating expense

11.59%136.29M

7.91%35M

1.91%32.21M

37.78%37.86M

1.98%31.23M

8.94%122.14M

-5.55%32.44M

47.71%31.6M

-11.02%27.48M

20.10%30.62M

Selling and administrative expenses

-8.23%27.65M

2.39%6.55M

-2.27%6.72M

-0.32%7.51M

-26.33%6.86M

2.88%30.13M

-44.29%6.4M

17.59%6.88M

34.13%7.54M

47.06%9.32M

-General and administrative expense

-8.23%27.65M

2.39%6.55M

-2.27%6.72M

-0.32%7.51M

-26.33%6.86M

2.88%30.13M

-44.29%6.4M

17.59%6.88M

34.13%7.54M

47.06%9.32M

Research and development costs

18.10%108.51M

9.25%28.42M

3.08%25.45M

52.27%30.31M

14.39%24.33M

11.10%91.88M

13.92%26.01M

59.15%24.69M

-21.09%19.91M

11.20%21.27M

Depreciation amortization depletion

1.56%130K

21.88%39K

-3.13%31K

-9.38%29K

2.40%128K

0.00%32K

3.23%32K

-Depreciation and amortization

1.56%130K

21.88%39K

-3.13%31K

-9.38%29K

2.40%128K

0.00%32K

3.23%32K

Operating profit

-38.80%-121.5M

-4.15%-32.61M

-21.19%-28.9M

-623.17%-32.34M

0.94%-27.65M

1.74%-87.54M

6.61%-31.31M

-2,021.44%-23.85M

85.52%-4.47M

-18.46%-27.91M

Net non-operating interest income expense

-604K

Non-operating interest expense

--604K

----

--0

----

Other net income (expense)

73.99%3.59M

-9.71%874K

30.23%866K

223.68%861K

508.02%985K

221.03%2.06M

591.43%968K

499.10%665K

103.05%266K

-37.69%162K

Other non- operating income (expenses)

73.99%3.59M

-9.71%874K

30.23%866K

223.68%861K

508.02%985K

221.03%2.06M

591.43%968K

499.10%665K

103.05%266K

-37.69%162K

Income before tax

-38.65%-118.51M

-6.59%-32.34M

-20.93%-28.03M

-648.43%-31.48M

3.91%-26.67M

3.35%-85.47M

9.12%-30.34M

-2,188.25%-23.18M

86.32%-4.21M

-19.09%-27.75M

Income tax

Net income

-38.65%-118.51M

-6.59%-32.34M

-20.93%-28.03M

-648.43%-31.48M

3.91%-26.67M

3.35%-85.47M

9.12%-30.34M

-2,188.25%-23.18M

86.32%-4.21M

-19.09%-27.75M

Net income continuous Operations

-38.65%-118.51M

-6.59%-32.34M

-20.93%-28.03M

-648.43%-31.48M

3.91%-26.67M

3.35%-85.47M

9.12%-30.34M

-2,188.25%-23.18M

86.32%-4.21M

-19.09%-27.75M

Minority interest income

Net income attributable to the parent company

-38.65%-118.51M

-6.59%-32.34M

-20.93%-28.03M

-648.43%-31.48M

3.91%-26.67M

3.35%-85.47M

9.12%-30.34M

-2,188.25%-23.18M

86.32%-4.21M

-19.09%-27.75M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-38.65%-118.51M

-6.59%-32.34M

-20.93%-28.03M

-648.43%-31.48M

3.91%-26.67M

3.35%-85.47M

9.12%-30.34M

-2,188.25%-23.18M

86.32%-4.21M

-19.09%-27.75M

Basic earnings per share

-37.74%-2.19

-7.14%-0.6

-20.93%-0.52

-625.00%-0.58

5.77%-0.49

8.62%-1.59

11.11%-0.56

-2,050.00%-0.43

86.89%-0.08

-10.64%-0.52

Diluted earnings per share

-37.74%-2.19

-7.14%-0.6

-20.93%-0.52

-625.00%-0.58

5.77%-0.49

8.62%-1.59

11.11%-0.56

-2,050.00%-0.43

86.89%-0.08

-10.64%-0.52

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	-49.92%20.97M	-7.88%3M	-55.00%4.87M	-69.86%6.93M	28.71%6.17M	81.81%41.87M	297.20%3.26M	-46.66%10.81M	23M	147.55%4.79M
Operating revenue	-51.59%20.27M	-29.32%2.31M	-55.00%4.87M	-69.86%6.93M	28.71%6.17M	81.81%41.87M	297.20%3.26M	-46.66%10.81M	--23M	147.55%4.79M
Cost of revenue	-15.03%6.17M	-71.46%608K	-49.00%1.56M	1.42M	24.46%2.59M	7.27M	2.13M	3.06M	0	2.08M
Gross profit	-57.24%14.79M	111.85%2.4M	-57.36%3.31M	-76.02%5.52M	31.97%3.58M	50.26%34.6M	37.76%1.13M	-61.73%7.76M	23M	40.00%2.71M
Operating expense	11.59%136.29M	7.91%35M	1.91%32.21M	37.78%37.86M	1.98%31.23M	8.94%122.14M	-5.55%32.44M	47.71%31.6M	-11.02%27.48M	20.10%30.62M
Selling and administrative expenses	-8.23%27.65M	2.39%6.55M	-2.27%6.72M	-0.32%7.51M	-26.33%6.86M	2.88%30.13M	-44.29%6.4M	17.59%6.88M	34.13%7.54M	47.06%9.32M
-General and administrative expense	-8.23%27.65M	2.39%6.55M	-2.27%6.72M	-0.32%7.51M	-26.33%6.86M	2.88%30.13M	-44.29%6.4M	17.59%6.88M	34.13%7.54M	47.06%9.32M
Research and development costs	18.10%108.51M	9.25%28.42M	3.08%25.45M	52.27%30.31M	14.39%24.33M	11.10%91.88M	13.92%26.01M	59.15%24.69M	-21.09%19.91M	11.20%21.27M
Depreciation amortization depletion	1.56%130K	21.88%39K	-3.13%31K	-3.13%31K	-9.38%29K	2.40%128K	0.00%32K	3.23%32K	3.23%32K	3.23%32K
-Depreciation and amortization	1.56%130K	21.88%39K	-3.13%31K	-3.13%31K	-9.38%29K	2.40%128K	0.00%32K	3.23%32K	3.23%32K	3.23%32K
Operating profit	-38.80%-121.5M	-4.15%-32.61M	-21.19%-28.9M	-623.17%-32.34M	0.94%-27.65M	1.74%-87.54M	6.61%-31.31M	-2,021.44%-23.85M	85.52%-4.47M	-18.46%-27.91M
Net non-operating interest income expense	-604K					0
Non-operating interest expense	--604K	----	----	----	----	--0	----	----	----	----
Other net income (expense)	73.99%3.59M	-9.71%874K	30.23%866K	223.68%861K	508.02%985K	221.03%2.06M	591.43%968K	499.10%665K	103.05%266K	-37.69%162K
Other non- operating income (expenses)	73.99%3.59M	-9.71%874K	30.23%866K	223.68%861K	508.02%985K	221.03%2.06M	591.43%968K	499.10%665K	103.05%266K	-37.69%162K
Income before tax	-38.65%-118.51M	-6.59%-32.34M	-20.93%-28.03M	-648.43%-31.48M	3.91%-26.67M	3.35%-85.47M	9.12%-30.34M	-2,188.25%-23.18M	86.32%-4.21M	-19.09%-27.75M
Income tax
Net income	-38.65%-118.51M	-6.59%-32.34M	-20.93%-28.03M	-648.43%-31.48M	3.91%-26.67M	3.35%-85.47M	9.12%-30.34M	-2,188.25%-23.18M	86.32%-4.21M	-19.09%-27.75M
Net income continuous Operations	-38.65%-118.51M	-6.59%-32.34M	-20.93%-28.03M	-648.43%-31.48M	3.91%-26.67M	3.35%-85.47M	9.12%-30.34M	-2,188.25%-23.18M	86.32%-4.21M	-19.09%-27.75M
Minority interest income
Net income attributable to the parent company	-38.65%-118.51M	-6.59%-32.34M	-20.93%-28.03M	-648.43%-31.48M	3.91%-26.67M	3.35%-85.47M	9.12%-30.34M	-2,188.25%-23.18M	86.32%-4.21M	-19.09%-27.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-38.65%-118.51M	-6.59%-32.34M	-20.93%-28.03M	-648.43%-31.48M	3.91%-26.67M	3.35%-85.47M	9.12%-30.34M	-2,188.25%-23.18M	86.32%-4.21M	-19.09%-27.75M
Basic earnings per share	-37.74%-2.19	-7.14%-0.6	-20.93%-0.52	-625.00%-0.58	5.77%-0.49	8.62%-1.59	11.11%-0.56	-2,050.00%-0.43	86.89%-0.08	-10.64%-0.52
Diluted earnings per share	-37.74%-2.19	-7.14%-0.6	-20.93%-0.52	-625.00%-0.58	5.77%-0.49	8.62%-1.59	11.11%-0.56	-2,050.00%-0.43	86.89%-0.08	-10.64%-0.52
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall